Noonan syndrome

Area of Science:

• Genetics
• Pediatrics
• Medical Diagnostics

Background:

• Noonan syndrome is a common autosomal dominant disorder with variable clinical presentation.
• Key features include facial dysmorphism, congenital heart defects, short stature, and learning disabilities.
• Diagnosis can be delayed in mildly affected individuals until a more severely affected child is born.

Purpose of the Study:

• To review the genetic basis of Noonan syndrome.
• To highlight the importance of molecular confirmation in diagnosis and management.
• To emphasize the role of increased pediatrician awareness in early detection and genetic counseling.

Main Methods:

• Review of germline mutations in the PTPN11 gene.
• Identification of mutations in other genes within the rat sarcoma (RAS) pathway.
• Discussion of molecular confirmation for diagnosis.

Main Results:

• Germline mutations in the PTPN11 gene explain approximately 50% of Noonan syndrome cases.
• Mutations in additional RAS pathway genes are identified in a portion of remaining cases.
• Molecular confirmation is now feasible for many families.

Conclusions:

• Molecular diagnosis is crucial for guiding Noonan syndrome management.
• Enhanced pediatrician awareness facilitates earlier diagnosis.
• Accurate genetic counseling, including reproductive options, is vital for families.